Hiv Seroconversion Prevention

HIV Seroconversion Prevention is a biomedical intervention strategy aimed at halting the transition from HIV exposure to established infection, distinguished by its reliance on timely administration of antiretroviral agents following potential viral exposure.

284

Publications

18.4K

Citations

1.9K

Authors

643

Institutions

Publications per year

2017–2026

61

Authors

1.9K

  1. DD
    Deborah Donnell

    Fred Hutch Cancer Center, United States

    8 publications · 578 citations

    8

    h-index

  2. JM
    Jared M. Baeten

    University of Washington, United States

    7 publications · 299 citations

    7

    h-index

  3. SB
    Susan Buchbinder

    San Francisco Department of Public Health, United States

    7 publications · 868 citations

    7

    h-index

  4. KH
    Kenneth H. Mayer

    Fenway Health, United States

    6 publications · 743 citations

    6

    h-index

  5. CC
    Connie Celum

    University of Washington, United States

    6 publications · 536 citations

    6

    h-index

1–5 of 1.9K

Venues

  1. AIDS

    29 publications · 1.6K citations

    22

    h-index

  2. PubMed

    Repository · 20 publications · 820 citations

    15

    h-index

  3. 15

    h-index

  4. AIDS and Behavior

    12 publications · 388 citations

    12

    h-index

  5. The Journal of Infectious Diseases

    JID · 12 publications · 1.7K citations

    12

    h-index

1–5